Unraveling the Role of Adjuvanted Flu Vaccines for Older High-Risk Patients
Stephen I. Pelton, MD
PeerMaximizing Flu Protection: The Clinical Value of Cell-Based Vaccines
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Assessing AKI Risk: Best Practices for Biomarker Testing
A Look at the Long-Term Data on a Therapy for Virologically Suppressed Adults
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Maximizing Flu Protection: The Clinical Value of Cell-Based Vaccines
Unveiling the Numerous Benefits of RTA Prefilled Syringes
Partial Response in Major Depressive Disorder Treatment: Are We Doing Enough?
Natalia Castillo Almeida, MD
PeerBrian P. McDonough, MD, FAAFP
Peer25 Must-Know Medical Abbreviations
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerNavigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC
Engaging Neuroplasticity in Depression with Cognitive-Emotional Training
Examining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs
Charulatha P. Nagar, MD
PeerCholangiocarcinoma: Treatment with Targeted Therapies
Treating Anti-AChR Antibody Positive gMG: Clinical Trials for 2 Treatment Options
Tuan H. Vu, MD
Peer